Ac Immune Stock In The News

ACIU Stock  USD 2.68  0.02  0.74%   
Our overall analysis of AC Immune's news coverage and content from conventional and social sources shows investors' bearish mood towards AC Immune. The specific impact of AC Immune news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AC Immune's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AC Immune headlines in addition to utilizing other, more conventional financial analysis modules. Check out AC Immune Backtesting and AC Immune Hype Analysis.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Today Top News and Investor Outlook

Yahoo News
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
https://finance.yahoo.com/news/ac-immune-takeda-sign-exclusive-100000010.html
 Bullish
Yahoo News
Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
https://finance.yahoo.com/news/down-35-7-4-weeks-143503312.html
 Bullish
Yahoo News
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
https://finance.yahoo.com/news/ac-immune-regain-global-rights-120000117.html
 Bullish
Yahoo News
AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
https://finance.yahoo.com/news/ac-immune-aciu-great-momentum-170005499.html
 Bullish
Yahoo News
5 Small-Cap Stocks to Play the January Effect
https://finance.yahoo.com/news/5-small-cap-stocks-play-145900292.html
 Bullish
Yahoo News
AC Immune (ACIU) Upgraded to Buy: Here's Why
https://finance.yahoo.com/news/ac-immune-aciu-upgraded-buy-170006780.html
 Bullish
Yahoo News
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
https://finance.yahoo.com/news/ac-immune-progress-phase-2-131000855.html
 Bullish
Yahoo News
AC Immune Announces Pricing of Underwritten Offering of Common Shares
https://finance.yahoo.com/news/ac-immune-announces-pricing-underwritten-125600169.html
 Bullish
Yahoo News
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
https://finance.yahoo.com/news/ac-immune-targeted-anti-ptau-122200253.html
 Bullish
Yahoo News
AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investors
https://finance.yahoo.com/news/ac-immune-sas-nasdaq-aciu-104235870.html
 Bullish

AC Immune Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ACIU and other traded companies coverage with news coverage. We help investors stay connected with ACIU headlines for the 20th of December to make an informed investment decision based on correlating the impacts of news items on ACIU Stock performance. Please note that trading solely based on the AC Immune hype is not for everyone as timely availability and quick action are needed to avoid losses.
AC Immune's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help AC Immune investors visualize upcoming and past events in order to time the market based on AC Immune noise-free hype analysis.
AC Immune stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ACIU earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AC Immune that are available to investors today. That information is available publicly through ACIU media outlets and privately through word of mouth or via ACIU internal channels. However, regardless of the origin, that massive amount of ACIU data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AC Immune news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AC Immune relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AC Immune's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AC Immune alpha.

ACIU Largest EPS Surprises

Earnings surprises can significantly impact AC Immune's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-11-13
2017-09-30-0.13-0.15-0.0215 
2017-08-09
2017-06-30-0.16-0.140.0212 
2016-11-11
2016-09-30-0.16-0.18-0.0212 
2020-05-04
2020-03-31-0.14-0.110.0321 
2018-08-08
2018-06-30-0.22-0.190.0313 
2024-05-13
2024-03-31-0.14-0.18-0.0428 
View All Earnings Estimates

AC Immune Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AC Immune Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
Simply Wall St News at Macroaxis
19th of December 2024
AC Immune SAs last weeks 11 percent decline must have disappointed retail investors who ha...
at simplywall.st 
Yahoo News
10th of December 2024
AC Immune Reports Interim Safety Data from Phase 1b2 ABATE Trial of ACI-24.060 in Down syn...
at finance.yahoo.com 
news
5th of December 2024
Redmile Group LLC Has 6.40 Million Stake in AC Immune SA
at thelincolnianonline.com 
benzinga news
14th of November 2024
AC Immunes Active Immunotherapy Shows Antibody Responses In Early Parkinsons Patients
at benzinga.com 
news
6th of November 2024
AC Immune Earns Buy Rating from HC Wainwright
at thelincolnianonline.com 
Yahoo News
5th of November 2024
AC Immune Q3 Earnings Snapshot
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
23rd of October 2024
What To Expect From AC Immune SA Q3 2024 Earnings
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AC Immune in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AC Immune's short interest history, or implied volatility extrapolated from AC Immune options trading.

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.